{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Availability of Lomustine for Glioblastoma Multiforme","description":" Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage. ","author_name":"Neurology\u00ae Podcast","author_url":"https:\/\/www.neurology.org\/podcast","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/22793045\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/006d48\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/22793045"}